This smart contact lenses can diagnose cancer from tears : The Tribune India

This smart contact lenses can diagnose cancer from tears

This smart contact lenses can diagnose cancer from tears

Photo for representation only.



New York, August 16

US scientists have developed a contact lens that can help in the early detection of cancer using tears and help in the treatment.

The novel lens, developed by the team at the Terasaki Institute for Biomedical Innovation (TIBI) in California, is able to capture and detect exosomes, the nanometer-sized vesicles found in bodily secretions that have the potential for being diagnostic cancer biomarkers.

The lens was designed with microchambers bound to antibodies that can capture exosomes found in tears. This antibody-conjugated signalling microchamber contact lens (ACSM-CL) can be stained for detection with nanoparticle-tagged specific antibodies for selective visualisation.

This offers a potential platform for cancer pre-screening and a supportive diagnostic tool that is easy, rapid, sensitive, cost-effective, and non-invasive.

Exosomes are formed within most cells and secreted into many bodily fluids, such as plasma, saliva, urine, and tears. Once thought to be the dumping grounds for unwanted materials from their cells of origin, it is now known that exosomes can transport different biomolecules between cells.

But, the TIBI team devised their ACSM-CL for capturing exosomes from tears, an optimum and cleaner source of exosomes than blood, urine, and saliva.

"Exosomes are a rich source of markers and biomolecules which can be targeted for several biomedical applications," said Ali Khademhosseini, TIBI's Director and CEO.

"The methodology that our team has developed greatly facilitates our ability to tap into this source." In an initial validation experiment, the ACSM-CL was tested against exosomes secreted into supernatants from ten different tissue and cancer cell lines. The ability to capture and detect exosomes was validated by the spectroscopic shifts observed in all the test samples, in comparison with the negative controls.

Similar results were obtained when the ACSM-CL was tested against ten different tear samples collected from volunteers.

In final experiments, exosomes in supernatants collected from three different cell lines with different surface marker expressions were tested against the ACSM-CL, along with different combinations of marker-specific detection antibodies.

The resultant patterns of detection and non-detection of exosomes from the three different cell lines were as expected, thus validating the ACSM-CL's ability to accurately capture and detect exosomes with different surface markers.

IANS

Tribune Shorts


Top News

Health Minister Mandaviya launches Bharat Biotech’s nasal Covid vaccine

Mandaviya unveils world’s first intranasal Covid vaccine ‘iNCOVACC’

The nasal vaccine—BBV154 -- had received DCGI approval in No...

President Murmu to lead nation in celebrating 74th R-Day; 6 Agniveers to also take part in parade

India celebrates 74th Republic Day on Kartavya Path; showcases military might, cultural heritage

Egypt's President Abdel Fattah al-Sisi is the chief guest at...

Chandigarh Administration declares holiday on Jan 28

Chandigarh Administration declares holiday on January 28

Announcement was made by Adviser to the UT Administrator Dha...

As Big Tech is firing employees by thousands, what is driving layoffs and how worried should we be

As Big Tech is firing employees by thousands, what is driving layoffs and how worried should we be

In the last year, more than 70,000 people globally have been...


Cities

View All